GALWAY, IRELAND--April 12, 2023--Written by Martin Lynch, European News Editor for Industrial Info (Galway, Ireland)--Pharma major Eli Lilly (NYSE:LLY) (Indianapolis, Indiana) is to more than double its investment to US$1 billion in a new biologics drug substance manufacturing facility in Limerick, Ireland. Within this article: Details doubling of investment in new plant, scope, timeline, additional solar project
(All Fields Required)
Site-wide Scheduled Maintenance for April 12, 2025, between 9 A.M. - 9 P.M. CST. During this time, all services will be unavailable periodically throughout the scheduled maintenance window.
×For More Info!
